Invesaro

Stocks CRBP Earnings

Earnings

Corbus Pharmaceuticals Holdings, Inc. (CRBP) earnings

Quarterly results of Corbus Pharmaceuticals Holdings, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when CRBP files with the SEC.

Next earnings date

Corbus Pharmaceuticals Holdings, Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Corbus Pharmaceuticals Holdings, Inc. reported revenue of - and a net loss of $35M.

Diluted earnings per share were -$1.81.

Filed with the SEC on August 6, 2026.

Net income by quarter
Q3 24: -$13.8M -$13.8M Q3 24Q4 24: -$9.5M -$9.5M Q4 24Q1 25: -$17M -$17M Q1 25Q2 25: -$17.7M -$17.7M Q2 25Q3 25: -$23.3M -$23.3M Q3 25Q4 25: -$20.6M -$20.6M Q4 25Q1 26: -$23M -$23M Q1 26Q2 26: -$35M -$35M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026---$35M-$1.81
Q1 FY2026March 31, 2026---$23M-$1.23
Q4 FY2025December 31, 2025---$20.6M-
Q3 FY2025September 30, 2025---$23.3M-$1.90
Q2 FY2025June 30, 2025---$17.7M-$1.44
Q1 FY2025March 31, 2025---$17M-$1.39
Q4 FY2024December 31, 2024---$9.5M-
Q3 FY2024September 30, 2024---$13.8M-$1.15

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Corbus Pharmaceuticals Holdings, Inc.'s next earnings date?

Corbus Pharmaceuticals Holdings, Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when CRBP reports

Follow CRBP and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when CRBP files with the SEC.

Source: quarterly figures Corbus Pharmaceuticals Holdings, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Corbus Pharmaceuticals Holdings, Inc.